Results

eNauka >  Results >  Amifampridine Phosphate in patients with Lambert-Eaton myasthenic syndrome (LEMS): a phase 3, multicentre, double-blind, placebo-controlled trial
Title: Amifampridine Phosphate in patients with Lambert-Eaton myasthenic syndrome (LEMS): a phase 3, multicentre, double-blind, placebo-controlled trial
Authors: Schoser, B; Oh, S; Shcherbakova, N; Kostera-Pruszczyk, A; Alsharabati, M; Dimachkie, M; Blanco, JM; Lavrnic, Dragana V; Shieh, P; Vial, C;
Meisel, Andreas; Brannagan, T; Komoly, S; Sivakumar, K; So, Y;
Issue Date: 2016
Publication: EUROPEAN JOURNAL OF NEUROLOGY
ISSN: 1351-5101 European Journal of Neurology Search Idenfier
Type: Conference Paper
Collation: vol. 23 str. 690-691
WoS-ID: 000431634203162
URI: https://enauka.gov.rs/handle/123456789/818507
Project: BioMarin Pharmaceutical Inc.
Catalyst Pharmaceuticals Inc.
Alnylam
ISIS Pharmaceuticals
Novartis
BioMarin
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Find the DOI

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.